FDA panel supports patisiran for ATTR amyloidosis with cardiomyopathy healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
The FDA CRDAC convened on Septemeber 13 to discuss the sNDA for patisiran as a treatment for ATTR-CM, with the meeting concluding in a 9:3 vote in favor of the benefit-risk profile of patisiran.
Suede dominates the 2023 Aranya Xiami Music Festival, rocking the Aranya Beach for three days sinchew.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sinchew.com.my Daily Mail and Mail on Sunday newspapers.